Keyword: Willis Towers Watson
As the COVID-19 pandemic has brought far-reaching changes to the workforce, employers are adapting their approaches to health and wellness benefits.
Employers could face significant benefit cost increases due to the COVID-19 pandemic, a new analysis shows.
Sleep is the latest in an ever-growing list of wellness issues that firms are targeting to improve workers’ health and lower medical costs.
Insurers are especially worried about the growing impact of mental health costs.
Employers are looking to change the location for administering specialty drugs as one of the strategies to rein in high drug prices, a survey found.
Specialty drugs made up 1% of prescriptions for employers but accounted for 40% of total drug spending last year, an analysis found.
When it comes to healthcare, employers ranked offering choices and decision support tools as their top healthcare priority in 2019.
A majority of employers have no plans to focus on opioid abuse or suicide prevention, according to a new report.
